The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology ...

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...

"Fueled by advances in NGS and precision medicine, China’s DNA sequencing market sees rapid growth amid strong government support, rising clinical applications, and innovation hubs in Guangdong, ...

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

PhD Defense: Detectie van pathogenen door middel van liquid biopsy shotgun sequencing ...

Antibiotic resistance is quietly spreading worldwide. According to the World Health Organization's (WHO) latest Global ...

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement with MGI Tech and Complete Genomics, USA, granting Swiss Rockets a perpetual, ...

Cancer charities also in attendance at the session, entitled ‘Closing the Gap: Bringing Cancer Genomic Testing to Scottish ...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage leader in regenerative and cellular innovation, today announced the official launch of ...

The United States Tumor Profiling Market is projected to surge from US$ 3.41 billion in 2024 to US$ 7.44 billion by 2033, ...